These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22892175)

  • 1. The association of statin therapy and high-sensitivity C-reactive protein level for predicting clinical outcome in acute non-cardioembolic ischemic stroke.
    Tsai NW; Lee LH; Huang CR; Chang WN; Chen SD; Wang HC; Lin YJ; Lin WC; Chiang YF; Lin TK; Cheng BC; Su YJ; Kung CT; Hung SH; Chang HW; Lu CH
    Clin Chim Acta; 2012 Nov; 413(23-24):1861-5. PubMed ID: 22892175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.
    Cappellari M; Deluca C; Tinazzi M; Tomelleri G; Carletti M; Fiaschi A; Bovi P; Moretto G
    J Neurol Sci; 2011 Sep; 308(1-2):128-34. PubMed ID: 21683374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
    McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
    Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
    Koton S; Molshatzki N; Bornstein NM; Tanne D
    Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population.
    Song IU; Kim JS; Kim YI; Lee KS; Jeong DS; Chung SW
    Cerebrovasc Dis; 2009; 28(6):545-50. PubMed ID: 19844093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy.
    Lee KK; Cipriano LE; Owens DK; Go AS; Hlatky MA
    Circulation; 2010 Oct; 122(15):1478-87. PubMed ID: 20876434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein.
    Jeong HC; Ahn Y; Hong YJ; Kim JH; Jeong MH; Kim YJ; Chae SC; Cho MC;
    Int J Cardiol; 2013 Sep; 167(5):1848-53. PubMed ID: 22592028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering C-reactive protein with statins after an ischemic stroke avoids mortality and readmissions. A prospective cohort study.
    Arévalo-Lorido JC; Carretero-Gómez J; Fernández-Recio JM; Alvarez-Oliva A; Gutiérrez-Montaño C; Najarro-Díez F; Martín-Sánchez MJ
    Ann Med; 2015 May; 47(3):226-32. PubMed ID: 25895539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ankle brachial index (ABI), high sensitivity C-reactive protein (hs-CRP) and initial disability level in acute ischemic stroke.
    Chotik-anuchit S; Nilanont Y; Poungvarin N
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S94-8. PubMed ID: 21728273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in Nigeria.
    Abubakar SA; Okubadejo NU; Ojo OO; Oladipo O; Ojini FI; Danesi MA
    Niger J Clin Pract; 2013; 16(3):320-4. PubMed ID: 23771453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.
    Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
    J Atheroscler Thromb; 2017 Oct; 24(10):1039-1047. PubMed ID: 28302952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A significant temporal and quantitative relationship exists between high-density lipoprotein levels and acute ischemic stroke presentation.
    Russman AN; Schultz LR; Zaman IF; Rehman MF; Silver B; Mitsias P; Nerenz DR
    J Neurol Sci; 2009 Apr; 279(1-2):53-6. PubMed ID: 19195663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.
    Yoshika M; Komiyama Y; Masuda M; Yokoi T; Masaki H; Ohkura H; Takahashi H
    Clin Exp Hypertens; 2010; 32(6):341-6. PubMed ID: 21028996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
    Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
    Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on the correlation between high sensitivity C-reactive protein and risk factors in cerebral vessel [corrected] disease].
    Zhou WJ; Tong JJ; Ye J; Lu YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):325-8. PubMed ID: 17577433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.